Rabbit Monoclonal CD22 phospho Y822 antibody. Suitable for Flow Cyt, Dot, WB and reacts with Human, Synthetic peptide samples. Cited in 3 publications.
View Alternative Names
CD22, SIGLEC2, B-cell receptor CD22, B-lymphocyte cell adhesion molecule, Sialic acid-binding Ig-like lectin 2, T-cell surface antigen Leu-14, BL-CAM, Siglec-2
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD22 (phospho Y822) antibody [Y506] (AB32123)
Flow cytometric analysis of permeabilized K562 cells, untreated (green) or Pervanadate treated (red) using ab32123
- WB
Unknown
Western blot - Anti-CD22 (phospho Y822) antibody [Y506] (AB32123)
All lanes:
Western blot - Anti-CD22 (phospho Y822) antibody [Y506] (ab32123) at 1/1000 dilution
Lane 1:
Untreated Raji cell lysate
Lane 2:
Raji cell lysate treated with Pervanadate
Predicted band size: 95 kDa
Observed band size: 150 kDa
false
- WB
Unknown
Western blot - Anti-CD22 (phospho Y822) antibody [Y506] (AB32123)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CD22 (phospho Y822) antibody [Y506] (ab32123) at 1/1000 dilution
Lane 1:
Ramos (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 10 µg
Lane 2:
Ramos treated with 1mM pervanadate for 30 min whole cell lysate at 10 µg
Lane 3:
Ramos treated with 1mM pervanadate for 30 min whole cell lysate. Then the membrane was incubated with alkaline phosphatase. at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 150 kDa
false
- Dot
Unknown
Dot Blot - Anti-CD22 (phospho Y822) antibody [Y506] (AB32123)
Dot blot analysis of CD22 (phospho Y822) phospho peptide (Lane 1) and CD22 non-phospho peptide (Lane 2) labelling CD22 (phospho Y822) with ab32123 at a dilution of 1/1000. A Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1/20,000. Blocking buffer : 5% NFDM/TBST. Dilution buffer : 5% NFDM /TBST.
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD22 acts mainly as a negative regulator of B cell receptor (BCR) signaling. It is part of a complex that interacts with the BCR and other accessory molecules. CD22 helps maintain B cell tolerance by inhibiting overactive signaling and preventing autoimmune responses. By binding to sialic acid-containing glycans CD22 modulates interactions between B cells and other cells aiding in the maintenance of immune homeostasis.
Pathways
CD22 plays a critical role in the BCR signaling pathway and the regulation of phosphatidylinositol 3-kinase (PI3K) signaling. It works together with proteins like CD19 and SHP-1 that are key components of these pathways. By influencing these signaling cascades CD22 contributes to the modulation of B cell activation proliferation and apoptosis ensuring proper functioning of the immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature immunology 24:1762-1777 PubMed37653247
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 112:E6515-24 PubMed26561584
2015
Applications
Unspecified application
Species
Unspecified reactive species
Blood 116:1698-704 PubMed20516366
2010
Applications
Flow Cyt
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com